Ashleigh Rogers
Long/short equity, growth at reasonable price, value, banks

Acquisitive AmSurg Corp Deserves Its Rich Multiple

In the healthcare space, it is somewhat rare to find a true growth company. Most of the growth companies that people talk about in the industry are really medical device companies or drug companies. AmSurg (NASDAQ:AMSG) is definitely an exception to this rule though. The company is involved in acquiring and developing ambulatory surgery centers in partnership with physicians groups around the country. Trading at roughly 19X trailing EPS (and ~16.5X CY 2014 expected EPS), AMSG definitely is not cheap. That said, this premium valuation is more than fully justified by the company's roughly 14% average annual sales growth rate and 10% average annual net income growth rate over the last decade. AMSG has been remarkably consistent on...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details